NO993928L - Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium - Google Patents
Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammoniumInfo
- Publication number
- NO993928L NO993928L NO993928A NO993928A NO993928L NO 993928 L NO993928 L NO 993928L NO 993928 A NO993928 A NO 993928A NO 993928 A NO993928 A NO 993928A NO 993928 L NO993928 L NO 993928L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- weight
- quaternary ammonium
- oral administration
- heterocyclic compounds
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Abstract
Oppfinnelsen angår et farmasøytisk preparat for oral administrering av heterocykliske forbindelser i form av kvaternært ammonium, inneholdende aktivt prinsipp hydrofilt løsemiddel anionisk overflateaktivt middel polysorbat 80 makrogoglycerid QS opptil 0,1 tiM5vekt% O til 60 vekt% O til 5 vekt% O til 5 vekt% 100vekt%, forutsatt at minst en bestanddel valgt fra det hydrofile løsemiddel og anioniske overflateaktive middel er til stede.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9701825A FR2759584B1 (fr) | 1997-02-17 | 1997-02-17 | Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire |
PCT/FR1998/000298 WO1998035662A1 (fr) | 1997-02-17 | 1998-02-17 | Composition pharmaceutique pour l'administration orale de composes heterocycliques sous forme ammonium quaternaire |
Publications (2)
Publication Number | Publication Date |
---|---|
NO993928L true NO993928L (no) | 1999-08-16 |
NO993928D0 NO993928D0 (no) | 1999-08-16 |
Family
ID=9503804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO993928A NO993928D0 (no) | 1997-02-17 | 1999-08-16 | Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0969825A1 (no) |
JP (1) | JP2001511795A (no) |
AR (1) | AR011805A1 (no) |
AU (1) | AU6404998A (no) |
BR (1) | BR9807694A (no) |
CA (1) | CA2281560A1 (no) |
FR (1) | FR2759584B1 (no) |
HR (1) | HRP980075A2 (no) |
NO (1) | NO993928D0 (no) |
WO (1) | WO1998035662A1 (no) |
ZA (1) | ZA981289B (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102188424B (zh) * | 2011-03-23 | 2013-03-27 | 浙江理工大学 | Sr140333的抗血癌作用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676055B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Composes polycycliques amines et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2676054B1 (fr) * | 1991-05-03 | 1993-09-03 | Sanofi Elf | Nouveaux composes n-alkylenepiperidino et leurs enantiomeres, procede pour leur preparation et compositions pharmaceutiques les contenant. |
FR2688219B1 (fr) * | 1992-03-03 | 1994-07-08 | Sanofi Elf | Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant. |
FR2696178B1 (fr) * | 1992-09-30 | 1994-12-30 | Sanofi Elf | Amides basiques quaternaires, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
FR2717804B1 (fr) * | 1994-03-25 | 1996-06-21 | Sanofi Sa | Sels de composés hétéroaromatiques azotés substitués, procédé pour leur préparation et compositions pharmaceutiques en contenant. |
ES2132709T3 (es) * | 1994-08-25 | 1999-08-16 | Merrell Pharma Inc | Nuevas piperidinas substituidas utiles para el tratamiento de las enfermedades alergicas. |
FR2725986B1 (fr) * | 1994-10-21 | 1996-11-29 | Adir | Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2725900B1 (fr) * | 1994-10-21 | 1997-07-18 | Sanofi Sa | Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice |
FR2729951B1 (fr) * | 1995-01-30 | 1997-04-18 | Sanofi Sa | Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant |
FR2729954B1 (fr) * | 1995-01-30 | 1997-08-01 | Sanofi Sa | Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant |
-
1997
- 1997-02-17 FR FR9701825A patent/FR2759584B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-16 AR ARP980100675A patent/AR011805A1/es unknown
- 1998-02-16 HR HR9701825A patent/HRP980075A2/hr not_active Application Discontinuation
- 1998-02-17 WO PCT/FR1998/000298 patent/WO1998035662A1/fr not_active Application Discontinuation
- 1998-02-17 ZA ZA981289A patent/ZA981289B/xx unknown
- 1998-02-17 JP JP53543298A patent/JP2001511795A/ja active Pending
- 1998-02-17 AU AU64049/98A patent/AU6404998A/en not_active Abandoned
- 1998-02-17 EP EP98909549A patent/EP0969825A1/fr not_active Withdrawn
- 1998-02-17 BR BR9807694A patent/BR9807694A/pt not_active Application Discontinuation
- 1998-02-17 CA CA002281560A patent/CA2281560A1/en not_active Abandoned
-
1999
- 1999-08-16 NO NO993928A patent/NO993928D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
ZA981289B (en) | 1998-08-26 |
BR9807694A (pt) | 2000-03-21 |
FR2759584B1 (fr) | 1999-06-11 |
WO1998035662A1 (fr) | 1998-08-20 |
AU6404998A (en) | 1998-09-08 |
HRP980075A2 (en) | 1998-10-31 |
EP0969825A1 (fr) | 2000-01-12 |
NO993928D0 (no) | 1999-08-16 |
AR011805A1 (es) | 2000-09-13 |
CA2281560A1 (en) | 1998-08-20 |
FR2759584A1 (fr) | 1998-08-21 |
JP2001511795A (ja) | 2001-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954146L (no) | Belagte farmasöytiske preparater | |
FR2677984B1 (fr) | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. | |
FI973320A (fi) | Kiinteitä aktiiviainetta sisältäviä valmisteita | |
DK0449247T3 (da) | Farmaceutisk formulering indeholdende galanthamin til behandling af alkoholisme | |
NO934284L (no) | Farmasoeytisk preparat inneholdende et definert lipidsystem | |
NO304989B1 (no) | 11<beta>-benzaldoksim-°stra-4,9-dienderivater samt farmas°ytisk preparat inneholdende slike | |
FR2708606B1 (fr) | Dérivés du N-phénylalkylindol-2-one, leur préparation, les compositions pharmaceutiques en contenant. | |
NO20000466L (no) | Farmasøytisk preparat for sure, lipofile forbindelser i form av en selvregulerende formulering | |
ATE148630T1 (de) | Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen | |
GR1002295B (el) | Στερεες φαρμακευτικες συνθεσεις και μεθοδος για την παρασκευη τους. | |
DK0648779T3 (da) | 11-benzaldoxim-17beta-methoxy-17alfa-methoxymethyl-estradien-derivater, fremgangsmåder til deres fremstilling og lægemidler indeholdende disse forbindelser | |
FR2681067B1 (fr) | Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant. | |
PT1078627E (pt) | Formulacao farmaceutica compreendendo amoxicilina e clavulanato | |
HU9300202D0 (en) | Benzo-pyrane derivatives, pharmaceutical preparatives containing them as active substance as well as method for producing them | |
NO993928L (no) | Farmasöytisk blanding for oral administrasjon av heterosykliske forbindelser i form av kvaternær ammonium | |
ATE316788T1 (de) | Medikament gegen pulmonale herzprobleme | |
DK0624365T3 (da) | Farmaceutisk form til rectal administrering af farmakologisk aktive forbindelser | |
DK0986390T3 (da) | Farmaceutiske præparater med cinchosin-dihydrochlorid | |
DE69000806D1 (de) | Indol-derivate. | |
ATE335491T1 (de) | Arzneimittel gegen glomerulosclerose | |
ITMI911653A1 (it) | Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
IT9022371A0 (it) | Derivati dell'1-arilsolfonil 2-pirrolidone, loro procedimento di preparazione e i nuovi intermedi cosi' ottenuti, il loro impiego come farmaci e le composizioni farmaceutiche che li contengono. | |
FR2691630B1 (fr) | Composition pharmaceutique, en particulier pour l'administration orale, contenant, comme ingrédient actif, un agoniste sélectif des récepteurs de type 5HT1. | |
ITMI922832A1 (it) | DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO. | |
ATE181828T1 (de) | Oral anzuwendendes arzneimittel bestehend aus ibuprofen |